Send to

Choose Destination
Clin Nutr Res. 2017 Apr;6(2):130-135. doi: 10.7762/cnr.2017.6.2.130. Epub 2017 Apr 30.

Nicotinamide Reduces Amyloid Precursor Protein and Presenilin 1 in Brain Tissues of Amyloid Beta-Tail Vein Injected Mice.

Author information

Department of Food and Nutrition, Chonnam National University, Gwangju 61186, Korea.
Department of Food and Nutrition, Seoul Women's University, Seoul 01797, Korea.


The purpose of this study is to investigate whether nicotinic acid (NA) and nicotinamide (NAM) reduce the Alzheimer disease (AD)-related gene expression in brain tissues of amyloid beta (Aβ)-injected mice. Male Crj:CD1 (ICR) mice were divided into 6 treatment groups; 1) control, 2) Aβ control, 3) Aβ + NA 20 mg/kg/day (NA20), 4) Aβ + NA40, 5) Aβ + NAM 200 mg/kg/day (NAM200), and 6) Aβ + NAM400. After 1-week acclimation period, the mice orally received NA or NAM once a day for a total of 7 successive days. On day 7, biotinylated Aβ42 was injected into mouse tail vein. At 5 hours after the injection, blood and tissues were collected. Aβ42 injection was confirmed by Western blot analysis of Aβ42 protein in brain tissue. NAM400 pre-treatment significantly reduced the gene expression of amyloid precursor protein and presenilin 1 in brain tissues. And, NAM200 and NAM400 pre-treatments significantly increased sirtuin 1 expression in brain tissues, which is accompanied by the decreased brain expression of nuclear factor kappa B by 2 doses of NAM. Increased expression of AD-related genes was attenuated by the NAM treatment, which suggests that NAM supplementation may be a potential preventive strategy against AD-related deleterious changes.


Aging; Alzheimer disease; Niacin; β-amyloid

Conflict of interest statement

Conflict of Interest: The authors declare that they have no competing interests.

Supplemental Content

Full text links

Icon for Korean Society of Clinical Nutrition Icon for PubMed Central
Loading ...
Support Center